Chlorodehydromethyltestosterone

Chlorodehydromethyltestosterone exerts its anabolic effects by binding to androgen receptors in muscle tissue. This promotes protein synthesis, leading to increased muscle growth and strength.

Unlike testosterone, CDMT is a 17α-alkylated steroid, which allows for oral bioavailability but also increases potential hepatotoxicity. It does not aromatize into estrogen, minimizing water retention and gynecomastia risk. Users report that the compound possesses a higher anabolic to androgenic ratio than many other steroids, contributing to its popularity in lean mass building cycles.

CDMT exhibits significant binding affinity to Sex Hormone-Binding Globulin (SHBG), reducing free testosterone levels. This can impact overall hormonal balance and necessitates careful cycle planning and post-cycle therapy.

Users report primarily researching Chlorodehydromethyltestosterone for its cutting and recomping properties. It’s frequently employed during periods where fat loss is prioritized while aiming to preserve lean muscle mass.

Athletes typically run CDMT cycles to enhance strength gains without substantial water retention or increases in body fat. While bulking cycles are less common, some users report combining it with other compounds for synergistic effects. It's also sometimes utilized as an adjunct during post-cycle therapy (PCT) to help mitigate muscle loss.

CDMT is not typically used as a primary strength-building compound due to the availability of more potent options; however, its ability to enhance protein synthesis contributes to noticeable improvements in power output over time. Research suggests it may also aid in recovery from intense training.

Intermediate users typically run Chlorodehydromethyltestosterone cycles ranging from 30-60 mg per day for a duration of 8–12 weeks. Advanced athletes may increase the dosage to 75 mg/day, but this is not generally recommended due to increased risk of hepatotoxicity.

Cycle lengths should rarely exceed 12 weeks to minimize liver stress. A common protocol involves starting with 30mg/day for the first two weeks, followed by an increase to 40-50mg/day for the remaining duration. Post-cycle therapy (PCT) is essential following a CDMT cycle.

Blood work monitoring is crucial throughout the cycle, including liver enzyme levels and lipid profiles. Cycles are often stacked with non-aromatizing compounds like Trenbolone Acetate or Primobolan to enhance synergistic effects, but this requires advanced knowledge of pharmacology and potential side effect management.

Chlorodehydromethyltestosterone is a 17α-alkylated steroid, making it hepatotoxic. Users report potential increases in liver enzyme levels with prolonged or high-dose use.

Common side effects include mild acne, increased aggression, and suppression of natural testosterone production. More severe side effects, though less frequent, can involve cholestasis (bile flow obstruction). It is strongly advised that users are over the age of 21 and have pre-existing liver health.

Post-cycle therapy (PCT) with SERMs like Clomiphene Citrate or Nolvadex is crucial to restore natural testosterone levels. Blood work should be conducted before, during, and after a cycle to monitor overall health. Long-term use of CDMT without adequate PCT can lead to significant hormonal imbalances.

Mechanism of action

Chlorodehydromethyltestosterone binds to androgen receptors, increasing protein synthesis and promoting muscle growth; its 17α-alkylation allows oral bioavailability but increases the risk of hepatotoxicity while exhibiting minimal aromatization.